These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26842877)

  • 1. Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis.
    Fucikova J; Becht E; Iribarren K; Goc J; Remark R; Damotte D; Alifano M; Devi P; Biton J; Germain C; Lupo A; Fridman WH; Dieu-Nosjean MC; Kroemer G; Sautès-Fridman C; Cremer I
    Cancer Res; 2016 Apr; 76(7):1746-56. PubMed ID: 26842877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
    Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
    Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calreticulin promotes tumor lymphocyte infiltration and enhances the antitumor effects of immunotherapy by up-regulating the endothelial expression of adhesion molecules.
    Wang HT; Lee HI; Guo JH; Chen SH; Liao ZK; Huang KW; Torng PL; Hwang LH
    Int J Cancer; 2012 Jun; 130(12):2892-902. PubMed ID: 21805477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.
    Talebian Yazdi M; van Riet S; van Schadewijk A; Fiocco M; van Hall T; Taube C; Hiemstra PS; van der Burg SH
    Oncotarget; 2016 Jan; 7(3):3477-88. PubMed ID: 26658106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis.
    Serrano Del Valle A; Beltrán-Visiedo M; de Poo-Rodríguez V; Jiménez-Alduán N; Azaceta G; Díez R; Martínez-Lázaro B; Izquierdo I; Palomera L; Naval J; Anel A; Marzo I
    Oncoimmunology; 2022; 11(1):2141973. PubMed ID: 36338146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy.
    Zhang Y; Akhil V; Seo HS; Park HR; Kim SH; You SH; Liu Z; Kim SY; Sultonova RD; Min JJ; Hong Y
    Theranostics; 2024; 14(3):1195-1211. PubMed ID: 38323311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer.
    Wang L; Guan R; Xie L; Liao X; Xiong K; Rees TW; Chen Y; Ji L; Chao H
    Angew Chem Int Ed Engl; 2021 Feb; 60(9):4657-4665. PubMed ID: 33217194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer.
    Fucikova J; Kasikova L; Truxova I; Laco J; Skapa P; Ryska A; Spisek R
    Immunol Lett; 2018 Jan; 193():25-34. PubMed ID: 29175313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.
    Shimizu K; Nakata M; Hirami Y; Yukawa T; Maeda A; Tanemoto K
    J Thorac Oncol; 2010 May; 5(5):585-90. PubMed ID: 20234320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer.
    Germain C; Gnjatic S; Tamzalit F; Knockaert S; Remark R; Goc J; Lepelley A; Becht E; Katsahian S; Bizouard G; Validire P; Damotte D; Alifano M; Magdeleinat P; Cremer I; Teillaud JL; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC
    Am J Respir Crit Care Med; 2014 Apr; 189(7):832-44. PubMed ID: 24484236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients.
    Djenidi F; Adam J; Goubar A; Durgeau A; Meurice G; de Montpréville V; Validire P; Besse B; Mami-Chouaib F
    J Immunol; 2015 Apr; 194(7):3475-86. PubMed ID: 25725111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
    Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
    Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia.
    Wemeau M; Kepp O; Tesnière A; Panaretakis T; Flament C; De Botton S; Zitvogel L; Kroemer G; Chaput N
    Cell Death Dis; 2010 Dec; 1(12):e104. PubMed ID: 21368877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Density of tumor-infiltrating FOXP3+ T cells as a response marker for induction chemoradiotherapy and a potential prognostic factor in patients treated with trimodality therapy for locally advanced non-small cell lung cancer.
    Tao H; Shien K; Soh J; Matsuda E; Toyooka S; Okabe K; Miyoshi S
    Ann Thorac Cardiovasc Surg; 2014; 20(6):980-6. PubMed ID: 24583705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity.
    Sethuraman SN; Singh MP; Patil G; Li S; Fiering S; Hoopes PJ; Guha C; Malayer J; Ranjan A
    Theranostics; 2020; 10(8):3397-3412. PubMed ID: 32206098
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway.
    Zitvogel L; Kepp O; Senovilla L; Menger L; Chaput N; Kroemer G
    Clin Cancer Res; 2010 Jun; 16(12):3100-4. PubMed ID: 20421432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner.
    Yang PM; Hsieh YY; Du JL; Yen SC; Hung CF
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: No association with prognosis identified in 3-year follow-up.
    Toomey D; Smyth G; Condron C; Kelly J; Byrne AM; Kay E; Conroy RM; Broe P; Bouchier-Hayes D
    Int J Cancer; 2003 Jan; 103(3):408-12. PubMed ID: 12471625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.
    Konishi J; Yamazaki K; Azuma M; Kinoshita I; Dosaka-Akita H; Nishimura M
    Clin Cancer Res; 2004 Aug; 10(15):5094-100. PubMed ID: 15297412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer.
    Chen CN; Chang CC; Su TE; Hsu WM; Jeng YM; Ho MC; Hsieh FJ; Lee PH; Kuo ML; Lee H; Chang KJ
    Ann Surg Oncol; 2009 Feb; 16(2):524-33. PubMed ID: 19050968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.